Back
Western Asset Emerging Markets Debt Fund Vs. Arcturus Therapeutics Holdings, Inc. Industry Stock Comparison
Buy
57
EMD
Western Asset Emerging Markets Debt Fund
Last Price:
$9.86
Seasonality Move:
2.33%
Sell
47
ARCT
Arcturus Therapeutics Holdings, Inc.
Last Price:
$8.02
Seasonality Move:
31.34%
Buy
57
Western Asset Emerging Markets Debt Fund (EMD)
is a Buy
Is Western Asset Emerging Markets Debt Fund a Buy, Sell or Hold?
-
The current Western Asset Emerging Markets Debt Fund [EMD] share price is $9.87. The Score for EMD is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
-
EMD is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
47
Arcturus Therapeutics Holdings, Inc. (ARCT)
is a Sell
Is Arcturus Therapeutics Holdings, Inc. a Buy, Sell or Hold?
-
The current Arcturus Therapeutics Holdings, Inc. [ARCT] share price is $8.03. The Score for ARCT is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
-
ARCT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
EMD Stock Price Chart
What is Western Asset Emerging Markets Debt Fund's stock price today?
-
The Western Asset Emerging Markets Debt Fund share price today is $9.87The current trend is relatively stagnant and EMD is experiencing slight buying pressure.
ARCT Stock Price Chart
What is Arcturus Therapeutics Holdings, Inc.'s stock price today?
-
The Arcturus Therapeutics Holdings, Inc. share price today is $8.03Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ARCT is experiencing slight buying pressure.
EMD Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.26 | Sell |
| Relative Strength Index (14 RSI): | 36.84 | Sell |
| Chaikin Money Flow: | 90745 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (9.91 - 10.67) | Sell |
| Bollinger Bands (100): | (10.32 - 11.02) | Sell |
ARCT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.04 | Buy |
| Relative Strength Index (14 RSI): | 62.43 | Buy |
| Chaikin Money Flow: | 180847 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (6.67 - 7.77) | Buy |
| Bollinger Bands (100): | (6.54 - 7.8) | Buy |
EMD Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 9.86 | Buy |
| 20-day SMA: | 10.16 | Sell |
| 50-day SMA: | 10.67 | Sell |
| 200-day SMA: | 10.47 | Sell |
| 8-day EMA: | 9.9 | Sell |
| 20-day EMA: | 10.15 | Sell |
| 50-day EMA: | 10.46 | Sell |
| 200-day EMA: | 10.43 | Sell |
ARCT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 7.26 | Buy |
| 20-day SMA: | 7.05 | Buy |
| 50-day SMA: | 7.39 | Buy |
| 200-day SMA: | 11.49 | Sell |
| 8-day EMA: | 7.41 | Buy |
| 20-day EMA: | 7.24 | Buy |
| 50-day EMA: | 7.41 | Buy |
| 200-day EMA: | 10.47 | Sell |
Western Asset Emerging Markets Debt Fund Earnings Growth & EMD Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Arcturus Therapeutics Holdings, Inc. Earnings Growth & ARCT Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.19 per share, an increase next quarter of $0.11 per share, a decrease this year of $1.91 per share, and a decrease next year of $0.18 per share.
Western Asset Emerging Markets Debt Fund Technical Analysis
| Mar 20 | Mar 23 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 30 | Mar 31 | Apr 1 | Apr 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | Apr | |||||||||
| 20 | 23 | 24 | 25 | 26 | 27 | 30 | 31 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Arcturus Therapeutics Holdings, Inc. Technical Analysis
| Mar 20 | Mar 23 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 30 | Mar 31 | Apr 1 | Apr 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | Apr | |||||||||
| 20 | 23 | 24 | 25 | 26 | 27 | 30 | 31 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||